End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.24 CHF | -.--% |
|
-.--% | -.--% |
Jul. 11 | Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating | MT |
Jul. 10 | Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43 | MT |
Performance
3 years | +22.19% | ||
5 years | +22.19% |
Volumes
marketsBasic data
Highs and lows
![Extreme 54.24](/images/extremecours_fleche.png)
![Extreme 54.24](/images/extremecours_fleche.png)
![Extreme 54.24](/images/extremecours_fleche.png)
![Extreme 44.39](/images/extremecours_fleche.png)
![Extreme 44.39](/images/extremecours_fleche.png)
![Extreme 44.39](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -.--% | -.--% | 83.35B | ||
-0.60% | +4.01% | +60.25% | +112.60% | 846B | ||
-0.91% | -0.28% | +38.56% | +86.99% | 628B | ||
+0.18% | +2.75% | -4.49% | -5.63% | 360B | ||
+1.31% | +2.48% | +18.30% | +18.65% | 322B | ||
+1.05% | +3.70% | +9.64% | +25.33% | 297B | ||
+0.18% | -0.05% | +14.15% | +20.02% | 240B | ||
+1.24% | +3.57% | +3.11% | -4.81% | 224B | ||
+1.00% | +2.10% | +16.98% | +16.02% | 223B | ||
+1.06% | +5.08% | +12.87% | +45.22% | 173B | ||
+1.09% | +3.47% | -0.45% | -20.43% | 161B | ||
+0.28% | +3.09% | +4.51% | -0.59% | 127B | ||
+1.77% | +5.08% | -13.63% | -8.08% | 85.65B | ||
0.00% | -0.36% | +3.78% | +14.19% | 78.83B | ||
+2.55% | +6.17% | +55.66% | +55.62% | 69.37B | ||
-0.64% | +4.16% | +18.94% | +66.25% | 65.06B | ||
Average | +0.35% | +2.64% | +14.89% | +26.33% | ||
Weighted average by Cap. | -0.03% | +2.56% | +24.40% | +45.64% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -.--% | ||
2023 | -.--% | ||
2022 | -.--% | ||
2021 | +22.19% | ||
2020 | -.--% | ||
2019 | -10.31% | ||
2018 | -17.52% | ||
2017 | -0.25% | ||
2016 | -12.76% | ||
2015 | +17.46% | ||
2014 | +7.41% |
- Stock Market
- Equities
- BMY Stock
- BMY Stock
- Quotes Bristol-Myers Squibb Company